Aurora Cannabis Inc (ACB)

[T-Tucker]

Great news about merger.

Aurora Cannabis Commences Compulsory Acquisition of Remaining CanniMed Shares
BY Canada NewsWire

— 6:30 AM ET 04/13/2018
TSX: ACB TSX: CMED
EDMONTON, April 13, 2018 /CNW/ - Aurora Cannabis Inc. ( ACBFF)
.
("Aurora") announced today that the Company has exercised its right under the compulsory acquisition provisions in Section 206 of the Canada Business Corporations Act (the "Act") to acquire all of the outstanding common shares (the "CanniMed Shares") of CanniMed Therapeutics Inc. ( CMMDF ) ("CanniMed") that it did not acquire under its recently completed offer (the "Offer") to acquire all of the issued and outstanding CanniMed Shares, by mailing a notice of compulsory acquisition (the "Notice of Compulsory Acquisition") to all remaining registered holders of CanniMed Shares. The compulsory acquisition is expected to be completed shortly after April 30, 2018. Intermediaries on behalf of beneficial holders will receive a notice from CDS.

Under the compulsory share acquisition, CanniMed shareholders must make an election no later than 5:00 p.m. on April 30, 2018 in accordance with the procedures in the Notice of Compulsory Acquisition mailed to registered shareholders, a copy of which is available under CanniMed's profile at www.SEDAR.com, and Section 206 of the Act.

To elect to receive the same consideration as that provided pursuant to the Offer, consisting of either 3.40 common shares of Aurora (the "Aurora Shares") (the "Share Alternative") or $43.00 in cash, subject to pro-ration (the "Cash Alternative"), per CanniMed Share, or any combination of Aurora Shares and cash based on a maximum of $43.00 in cash per CanniMed Share, with the cash being subject to the same pro-ration as the Cash Alternative (the "Share and Cash Alternative"), CanniMed shareholders must complete the letter of transmittal accompanying the Notice of Compulsory Acquisition and deliver it with the certificate(s) representing such shareholder's CanniMed Shares to Laurel Hill Advisory Group ("Laurel Hill") prior to 5:00 p.m. on April 30, 2018. Cash proration will be based on maximum cash available of approximately $6.0 million.
Shareholders who fail to elect will be deemed to have elected to receive Aurora Shares on the basis of 3.40 Aurora Shares for each CanniMed Share held.
Beneficial holders of CanniMed Shares must contact their broker for assistance in making their election. Questions and requests for assistance, including requests for additional copies of the Notice of Compulsory Acquisition and related letter of transmittal may be directed to Laurel Hill at 1-877-452-7184 for North America Toll Free or at 1-416-304-0211 for Collect Calls Outside North America ([e-mail]).

Aurora has taken up and paid for 23,512, 487 CanniMed Shares held by those shareholders who accepted the Offer and which represent approximately 93.1% of the outstanding CanniMed Shares. Aurora also purchased 700,600 CanniMed Shares in the open market during the period of the Offer, and in aggregate holds 95.9% of the outstanding CanniMed Shares.
Upon completion of the compulsory acquisition, Aurora intends to take the necessary steps to delist the CanniMed Shares from the TSX V and to have CanniMed cease to be a reporting issuer (or equivalent) under applicable Canadian securities law.